A number of biotech projects are under discussion with Academia and R&D centers.

Current leads focus on different tharepeutic areas mainly in rare diseases, such as oncology, haematology, cardiology and neurodegenerative.

We plan shortly alliances on  novel and repurposed compounds and to attract talented professionals, build a cross-country competence group and start the acceleration process of turning molecules into druggable candidates.

Individuals with a track record in any area of drug development are invited to contact infodesk@inorgen.com to discuss.

See more on Partnering.